# Cloud Biotechnology and Clinical Research Snowflake Data Platform Blueprint

**Connect study versions, participant visits, specimens, assays, and analysis snapshots while preserving blinding and protocol meaning.**


This biotechnology and clinical research data platform blueprint implements Data Vault on Snowflake using Fivetran, Flow.BI, dbt and DataHub. Follow the source workflow for Connect study versions, participant visits, specimens, assays, and analysis snapshots while preserving blinding and protocol meaning, then validate history, business rules, deployment and cost against the worked example.
Audience: sector operations, domain specialists, finance/commercial teams, security, governance, and data engineering. Updated: 5 November 2026.

[Industry platform selection guide](../cloud-biotechnology-and-clinical-research-platform-selection-guide.md) · [Sovereign edition](../../sovereign/sovereign-biotechnology-and-clinical-research-data-platform-blueprint.md) · [All blueprints](../../../../README.md)

## Tools behind the biotechnology and clinical research Snowflake platform

1. [Fivetran](https://fivetran.com/docs/getting-started) provides commercial managed replication for supported biotechnology and clinical research sources. Land EDC, trial management, randomization interfaces, laboratory/LIMS, biobanking, and approved analysis outputs in a destination-owned replica, retain sync/deletion evidence, and keep dbt-owned Vault tables separate.

2. [Flow.BI](https://flow.bi/) provides AI-assisted Data Vault modeling grounded in actual source data for study, protocol version, and site. Actual data is required; mostly optional source metadata improves modeling. Its customer-cloud Docker component profiles locally and sends derived metadata and statistical fingerprints to the backend.

3. [FCT](https://www.scalefree.com/consulting/turbovault/flowbi-connector/) (Flow.BI Connector for TurboVault4dbt) bridges Flow.BI and TurboVault by transferring the generated model in the required metadata form. [TurboVault](https://www.scalefree.com/consulting/turbovault/) turns the transferred metadata into dbt model files. Its generated models are reviewed before execution; request online TurboVault Studio access through Scalefree.

4. [datavault4dbt](https://github.com/ScalefreeCOM/datavault4dbt) encodes reusable Data Vault SQL patterns in a package consumed by dbt, while [dbt](https://github.com/dbt-labs/dbt) is the SQL transformation runtime and testing workflow for the generated and user-authored models. Additional user-authored Business Vault entities implement **protocol/visit mappings, specimen lineage, analysis-population membership, and frozen-data snapshot manifests** outside the regenerated paths.

5. [Snowflake](https://docs.snowflake.com/en/user-guide/cost-understanding-overall) is the database/compute target for biotechnology and clinical research: Snowflake is the managed SQL warehouse for storing integrated history and executing transformation/reporting workloads. Workload sizing and compute attribution remain architectural decisions. Choose Azure or AWS for the deployment described here according to data location and integration needs; the chosen cloud also supplies customer-side landing, profiling, and surrounding services.

6. [DataHub](https://docs.datahub.com/docs/ui-ingestion) provides cross-stack discovery, business definitions, ownership, and lineage for study, protocol version, and site; native platform permissions remain in force.

7. [Scalefree](https://www.scalefree.com/) brings architecture advice, hands-on implementation, Data Vault tooling, and training to platform projects. The engagement connects Snowflake implementation to the biotechnology and clinical research workflow, governed business rules, and team enablement.

## Snowflake data and model flow

```mermaid
flowchart TD
    SRC["Biotechnology and Clinical Research: approved source systems"] --> ING["Fivetran managed replication"]
    ING --> LAND["Controlled source landing"]
    subgraph TARGET["Snowflake on Azure or AWS"]
        LAND --> STG["Typed staging: source keys, timestamps and load evidence"]
        STG --> RV["Generated Raw Vault: source-attributed history"]
        RV --> BV["User-extended Business Vault"]
        BV --> PRODUCT["Biotechnology and Clinical Research: reconciled analytical products"]
    end
    LAND --> LOCAL["Flow.BI profiling Docker in customer Azure or AWS"]
    META["Optional source metadata"] --> LOCAL
    LOCAL -->|Derived metadata and statistical fingerprints| FLOW["Flow.BI backend: logical DV model"]
    FLOW --> FCT["FCT: model handoff"]
    FCT --> TURBO["TurboVault: generate dbt models"]
    TURBO --> REVIEW["Review generated dbt models"]
    REVIEW --> PROJECT["Versioned dbt project"]
    PROJECT --> RUN["datavault4dbt macros executed through dbt-snowflake"]
    RUN -. transforms .-> STG
    RUN -. loads .-> RV
    USER["Additional user-authored Business Vault entities"] --> CUSTOM["Versioned business rules and tests"]
    CUSTOM --> DBT["dbt business-model execution"]
    DBT -. builds .-> BV
    PROJECT -. supported model metadata .-> CAT["DataHub: glossary, owners and lineage"]
    RV -. validated warehouse metadata .-> CAT
    PRODUCT -. validated BI metadata .-> CAT
```

Source values for study, protocol version, and site are required for profiling. The local Docker component keeps raw source records in the customer environment during profiling and needs approved outbound backend connectivity for derived metadata and fingerprints. Flow.BI output goes directly through FCT and TurboVault; the review occurs after generation and before macro execution. Catalog edges represent configured integrations with tested coverage, including explicit lineage where automatic discovery is incomplete.

## Biotechnology and Clinical Research: operational workflow and source evidence

The first data product addresses this decision: **connect study versions, participant visits, specimens, assays, and analysis snapshots while preserving blinding and protocol meaning.** Start with one bounded business unit, contract/product family, site, or reporting period and name the owner of the resulting decision. The pilot draws from EDC, trial management, randomization interfaces, laboratory/LIMS, biobanking, and approved analysis outputs.

| Workflow stage | Evidence and interpretation to retain |
| --- | --- |
| Define the study | preserve protocol and amendment version |
| Enroll and visit | retain pseudonymous participant and visit events |
| Collect and assay | trace specimen/aliquot identity and result changes |
| Freeze and analyze | bind datasets to a declared cutoff and analysis plan |

Preserve the planned or promised position as well as actual execution. Maintain source-event time, business-effective time, arrival/load time, correction references, and the cutoff used for reporting. A late or missing delivery remains a visible data-quality state; it should not silently become zero activity.


## Data Vault entities and fact grain for biotechnology and clinical research

The business vocabulary includes **study, protocol version, site, participant pseudonym, visit, specimen, aliquot, assay run, result, and analysis snapshot**. The proposed fact grain is **study × participant pseudonym × visit/specimen × result version, with analysis populations separately defined**. Keep identifiers namespaced by the issuing system and organization. Distinguish source facts from estimates, allocations, approved business rules, and publication snapshots.

Flow.BI profiles required actual data; mostly optional source metadata improves results. Its output passes directly through **FCT → TurboVault → generated-model review → datavault4dbt/dbt execution**. The generated Raw Vault preserves source-attributed history. Users add Business Vault entities for **protocol/visit mappings, specimen lineage, analysis-population membership, and frozen-data snapshot manifests**. These user-authored extensions remain outside regenerated model paths.

Use the vocabulary to validate source semantics and define user-authored extensions. Review the generated implementation after TurboVault. Record the relevant package, adapter, generator, source-schema, rule, and runtime versions together.


## Worked biotechnology and clinical research example: calculation and reporting scope

A study has 100 enrolled participants but only 90 meet an explicitly defined analysis population. Eighty-one qualifying observations yield 90% completeness for that population, not 81% by silently switching to all enrollees. Population and missing-data rules require the approved analysis plan.

Keep the calculation's numerator, denominator, unit/currency, eligible population, business calendar, cutoff, exclusions, and rule version with the published product. Original evidence and corrected knowledge should support both reconstruction of the earlier report and a separately identified restatement.


## Corrections, exceptions, and access in biotechnology and clinical research

Exercise **amended consent, unscheduled visits, reassays, sample relabeling, and unblinding restrictions**. Build explicit associations for revisions and reversals so an event replay does not become a second business event. Measure reconciliation breaks at the fact grain before joining to descriptive or many-to-many relationships.

Protect **participant identities, genetic data, blinded allocation, consent restrictions, and sponsor/IP boundaries**. Establish purpose-specific permissions across direct SQL, BI, exports, and storage. Test revoked access and partner/client boundaries using the same routes consumers use. Retain source documents or large artifacts in an appropriate controlled repository and integrate authorized references and provenance.

[CDISC foundational standards](https://www.cdisc.org/standards/foundational) is a relevant reference for the design. Map the actual study, terminology, and implementation-guide versions. Approved analysis plans and research permissions remain authoritative for the product.

### Managed-cloud value and operating fit

Choose managed execution for measured delivery and operating benefits: faster product delivery, appropriate workload elasticity, reduced infrastructure administration, and useful integration. Retain the domain's confidentiality, safety, contractual, and records requirements. Platform features do not replace accountable business definitions or source reconciliation.


## Pilot ownership, acceptance, and rollout

Ownership is explicit: **clinical operations owns visits; laboratories own assays; statistics owns populations; research governance owns permitted use**. Engineers own connector behavior, pipeline state, generated-model releases and recovery. Governance owners approve processing purpose, field scope, external disclosure, and retention. The report/data-product owner decides how unresolved exceptions affect publication.

For acceptance, **rebuild a frozen snapshot, trace an aliquot, enforce blinding permissions, and propagate an authorized data correction**. Also demonstrate restart after a partial load, reproducible historical output, negative access tests, clean-environment recovery, and regeneration without losing Business Vault entities. Document thresholds and tolerances before assessing results rather than selecting them after a discrepancy appears.

Train business analysts on the worked example and denominator/grain choices. Train modelers using the sector's difficult cases, and require at least two internal operators to explain ingestion, review, execution, corrections, and restore. Extend one source or domain at a time after the pilot evidence and operating cost are accepted.


## Snowflake deployment and physical design

This is the **Snowflake implementation** of the biotechnology and clinical research workflow. Its purpose is **Connect study versions, participant visits, specimens, assays, and analysis snapshots while preserving blinding and protocol meaning**. Validate the selected target against the worked example and operational failure cases in this document. The platform comparison is available separately; this article carries the complete implementation, training, resources, and Next steps for this stack.

[Snowflake](https://docs.snowflake.com/en/user-guide/cost-understanding-overall) provides the managed SQL warehouse for biotechnology and clinical research. Land approved source deliveries, build staging and the Raw Vault with the tested Snowflake adapter, and implement protocol/visit mappings, specimen lineage, analysis-population membership, and frozen-data snapshot manifests as owned Business Vault models. Align the Azure or AWS account/region with the source estate, consumers, and operating skills.

Use distinct load, transformation, and reporting compute where the biotechnology and clinical research service windows need isolation. The evaluation must reconstruct historical study evidence and run concurrent consumers while applying a correction. Price compute, storage/retained copies, managed/serverless features used, transfer, and recovery; an AWS-to-Azure change is a migration decision with its own cost.

### Physical model and workload boundaries

Use separate landing, staging, Raw Vault, Business Vault, and serving schemas with explicit writer roles. A Fivetran-managed replica is an ingestion boundary; generated dbt models own the Vault. For study, protocol version, and site, preserve the source key namespace and business-effective timestamp alongside the load timestamp. Size transformation and reporting virtual warehouses independently where contention or charge attribution justifies it. Avoid adding clustering to every table: inspect the actual history lookup, join and correction profiles first.

### Historical rebuilds and release validation

Run the biotechnology and clinical research worked example through the pinned dbt-snowflake adapter and datavault4dbt package. Prove stable key/hash inputs, decimal/currency precision, timestamp interpretation, duplicate handling and satellite change detection. A late correction must update the appropriate historical interpretation without silently rewriting the previously published report. Exercise isolated development/release datasets and a restoration route; retention or cloning features have configured scope and cost and do not replace the recovery test.

### SQL serving, sharing and cost attribution

Publish protocol/visit mappings, specimen lineage, analysis-population membership, and frozen-data snapshot manifests through owned Business Vault models and approved serving contracts. Apply access policy to SQL, BI, extracts and any sharing route, and verify revoked access from the consumer identity. Measure loading, transformations and the close/reporting burst separately. Record query/warehouse evidence for each accepted batch; include idle compute, retries, retained data and edition-dependent features in the cost model. A feature such as additional acceleration or sharing requires a measured biotechnology and clinical research benefit and an approved release configuration.

### Ingestion contract

**Primary ingestion: Fivetran (commercial managed service).** Verify supported biotechnology and clinical research sources and the documented Snowflake destination, historical load/CDC scope, deleted-record behavior, schema changes, sync recovery and processing location. Keep its destination replica separate from dbt-owned models. Price the actual connector usage and destination load compute, including the plan-specific treatment of re-syncs; source-specific APIs or industrial/clinical gateways may still be needed. Use the [destination documentation](https://fivetran.com/docs/destinations) and [pricing definitions](https://fivetran.com/docs/core-concepts/usage-based-pricing).

### Platform acceptance and operating evidence

The release record contains Snowflake query history, dbt artifacts, reconciliation results, and warehouse usage. Join it to source delivery IDs, generator/package/adapter versions, model approval, calculation rule versions and publication cutoffs. Execute a duplicate, a late correction, partial-load recovery, regeneration without losing user-authored Business Vault entities, permission revocation and clean-environment restore using this industry's actual grain.

Measure **assay volumes, frozen snapshots, reanalysis, specialized compute, and validation effort**. Attribute normal refreshes, backfills, peak consumer demand, retries, retained history and staff effort separately. Report both cost per accepted source batch/data-product refresh and the meaningful business unit established in the worked example. A lower cost is useful only if correctness and the declared service target are maintained.

Use the difficult cases and acceptance exercise above as the platform benchmark. Compare cold and warm runs, record cache effects, and include the cost of a historical reconstruction. New streaming, AI, sharing, or semantic features enter the design only through a named use case, a supported regional/edition configuration, a measured benefit, and an incremental operating cost.

### Implementation documentation

Use the [Snowflake platform documentation](https://docs.snowflake.com/en/user-guide/cost-understanding-overall), [dbt-snowflake setup](https://docs.getdbt.com/docs/local/connect-data-platform/snowflake-setup), and [datavault4dbt supported platforms and documentation](https://www.datavault4dbt.com/) to pin the implementation. Feature availability and adapter/materialization behavior are part of the pilot acceptance record. Select each additional feature against a concrete biotechnology and clinical research use case and incremental operating cost.


## Operate and govern by data product

Assign each product a business owner, technical operator, purpose, grain, definitions, refresh target, classification, retention, and quality thresholds. Preserve source batch/offset IDs, code/package versions, calculation rules, cutoff, and exception status with published outputs. Keep operational-system decisions and regulated calculation engines within their validated authority boundaries.

Use institutional identity, scoped service principals, separate development/production, secret management, auditable privileged access, and approved network routes. Enforce restrictions through SQL, BI, export, and underlying storage. Test actual negative access and revocation behavior. A managed service or compliant provider does not establish application-level compliance.

Choose orchestration and alerts around the product's dependencies. A late source or unresolved material reconciliation break should affect publication status. Define retries and recovery of ingestion state, metadata/catalogs, data, credentials, and deployment artifacts. Demonstrate rollback and a clean-environment restore.


## Compare lifecycle cost and delivery value

The managed-cloud case is **shorter delivery time, reduced infrastructure administration, elastic execution, and useful platform integration**. The decision is an operating-model tradeoff. Keep privacy, contractual requirements, data-location constraints, and an exit plan even when sovereignty is not the main objective.

Use a three-year model with an explicit growth scenario:

`TCO = migration and implementation + platform/compute + storage and retained copies + ingestion/orchestration + network/egress + BI/security licenses + support + operating staff + recovery/testing + exit allowance`

Account for negotiated rates and existing commitments as incremental costs, without treating sunk licenses or staff effort as free. Measure normal, peak, backfill, and quiet-period workloads. Record costs per completed data-product refresh and per meaningful business unit, together with correctness and service quality. Compare low/base/high demand and sensitivity to refresh frequency, retention, concurrency, and source growth. Do not publish a cost-saving percentage without the corresponding workload and pricing assumptions.

For feature decisions, record the use case, production availability in the selected region/edition, integration limits, expected outcome, incremental cost, operating owner, and rollback. Prefer an ordinary SQL or scheduled pipeline when it meets the product goal more economically. New AI, streaming, or sharing capabilities should earn their place through a measured pilot.


## Delivery gates

1. Agree the product's grain, calculation, scope, cutoff, access, and reconciliation targets with its business owner.
2. Benchmark the recommended platform against the strongest alternative using the same sources and workload, including cold/warm runs and concurrent consumers.
3. Build the ingestion/model-generation path; review after TurboVault; run tested macros and add Business Vault rules.
4. Prove the industry's worked example and failure cases, historical reconstruction, permissions, restart, restore, and regeneration behavior.
5. Compare measured run cost and staff effort with the business case. Document limitations and choose the platform before committing to broad migration.


## Metadata stewardship in the biotechnology and clinical research stack

[DataHub](https://docs.datahub.com/docs/ui-ingestion) is the metadata catalog for this biotechnology and clinical research stack. It joins asset discovery, business definitions, ownership, and lineage so teams can trace study and understand the derived rules for protocol/visit mappings, specimen lineage, analysis-population membership, and frozen-data snapshot manifests.

Use DataHub Core in a customer-managed environment as the reference open-source catalog, or choose DataHub Cloud under an explicit service agreement. Budget catalog infrastructure/search, upgrades, credentials, metadata collection, and stewardship; a managed catalog adds its subscription and provider dependencies. This catalog complements the database's native access controls and, where present, Unity Catalog or a table-format metastore.

| Catalog responsibility | Implementation in this blueprint |
| --- | --- |
| Business meaning | For this product, register **study, protocol version, site, participant pseudonym, visit, specimen, aliquot, assay run, result, and analysis snapshot** as governed concepts linked to real assets. Describe **protocol/visit mappings, specimen lineage, analysis-population membership, and frozen-data snapshot manifests** with an owner, calculation/rule version, eligible population, cutoff, and known limitations. Publish only the metadata fields that the catalog users are authorized to see. |
| Metadata ingestion | Collect [dbt artifacts and target-warehouse metadata](https://docs.datahub.com/docs/generated/ingestion/sources/dbt) together so model nodes resolve to the actual tables/views. Select supported warehouse/BI sources and validate the Snowflake route and its warehouse/BI lineage coverage. For Fivetran-led ingestion, assess the [DataHub Fivetran source](https://docs.datahub.com/docs/generated/ingestion/sources/fivetran) for connector metadata/lineage coverage. Use explicit API-emitted lineage for unrepresented steps rather than assuming the full source-to-report path is automatic. |
| Quality and lineage evidence | dbt remains the execution/test layer; DataHub collects the supported metadata and quality results. Test which table/column lineage, test status, and deletion behavior are captured by the actual sources and artifact versions. |
| Release evidence | Catalog acceptance follows the biotechnology and clinical research pilot: trace an approved source field through a generated model and Business Vault extension to a published metric, then test a schema change, a stale scan, and a permission revocation. Mask sample values and sensitive SQL/descriptions where required. Track scan coverage and unresolved lineage gaps explicitly. |

## Training and knowledge transfer

Make capability development a delivery workstream with practical acceptance criteria.

| Track | Training resource | Participants | Proposed project outcome |
| --- | --- | --- | --- |
| DV — Data Vault | [Data Vault Training & Certification](https://www.scalefree.com/data-vault-2-1-trainings/data-vault-training-certification/) and [Modeling Class](https://www.scalefree.com/data-vault-2-1-trainings/data-vault-2-1-modeling-class/) | Architects, modelers, engineering leads; selected stewards for shared concepts. | Understand generated Raw Vault structures and design additional Business Vault entities with the correct keys, grain, and history. |
| DWA — Data Warehouse Automation | [Scalefree dbt training: DataVault4dbt and TurboVault automation blocks](https://www.scalefree.com/training/dbt-training/) | Modelers, engineers, and release owners. | Operate the Flow.BI–FCT–TurboVault workflow, review generated models before datavault4dbt/dbt execution, and regenerate without overwriting user-authored Business Vault entities. |
| dbt | [Scalefree dbt Training](https://www.scalefree.com/training/dbt-training/) | Data engineers, analytics engineers, and operators. | Build and test models, use packages/macros, debug failures, and promote releases through controlled environments. |
| Flow.BI foundations | [Flow.BI Introduction](https://flow.bi/trainings/flow-bi-introduction/) | Business analysts, domain stewards, architects, project leads, and engineers. | Understand the interface, data sources, deployment targets, and first model-generation run. |
| Flow.BI configuration and operations | [Flow.BI In-Depth](https://flow.bi/trainings/flow-bi-in-depth/) | Engineers, architects, and platform operators. | Configure classification, permissions, API access, and integration settings for the organization environment. |
| Understanding generated models | [Generated Data Vault Models](https://flow.bi/trainings/generated-data-vault-2-0-models/) | Data modelers, engineers, and architects. | Interpret generated structures and their downstream physical implementation; apply this knowledge to the review after TurboVault and to Business Vault extensions. |
| Flow.BI metadata presentation | [Presenting Flow.BI Metadata — training catalog](https://flow.bi/trainings/) | Modelers, analysts, and metadata/catalog owners. | Use Flow.BI dashboards to present internal metadata to authorized users. |
| Catalog stewardship | [DataHub documentation](https://docs.datahub.com/docs/ui-ingestion) | Data owners, stewards, catalog operators, and engineers. | Document study, approve definitions, trace model lineage, and operate metadata scans and access. |

**Terminology:** DWA means Data Warehouse Automation. The DWA training track uses Scalefree's published automation learning blocks. DVA refers exclusively to the Data Vault Alliance.

The Data Vault certification training covers Data Vault 2.1. Align the curriculum with the selected tool versions and implementation patterns. Its dbt offering is customizable; agree the agenda and prerequisites before booking.
Flow.BI In-Depth requires Flow.BI Introduction and general data-architecture knowledge. Generated Data Vault Models requires Flow.BI Introduction and Data Vault modeling knowledge. Use the [Flow.BI training catalog](https://flow.bi/trainings/) to select classes or a bundle and confirm current delivery details.

Recommended sequence:

1. Run DV foundations and modeling to understand the generated Raw Vault and design Business Vault extensions.
2. Complete Flow.BI Introduction before connecting the pilot sources; follow with In-Depth for the configuration and operations team and Generated Data Vault Models for modelers and engineers.
3. Run dbt fundamentals before building the first transformation pipeline.
4. Run DWA practical sessions when the first Flow.BI output is available for direct processing through FCT and TurboVault. Include metadata presentation training for the team publishing model documentation.
5. Complete an organization-led lab using synthetic datasets for the selected industry workflow: Fivetran ingestion, Flow.BI generation, direct FCT transfer, TurboVault generation, generated-model review, datavault4dbt/dbt execution, user-added Business Vault entities, and industry-specific reconciliation.
6. Require at least two internal operators to deploy, troubleshoot, restore, and explain the pipeline without external assistance.

Budget training, preparation time, labs, and follow-up coaching separately from software and hosting. Use the [current training catalog](https://www.scalefree.com/training/) for available formats and scheduling.


## Scalefree implementation resources

The following articles complement the product documentation and training. Read the Flow.BI/FCT integration overview first, then TurboVault generation, datavault4dbt staging and loading, and finally Business Vault extensions and deployment practices.

| Tool or topic | Scalefree blog resource | Application to this blueprint |
| --- | --- | --- |
| Flow.BI, FCT, TurboVault, and datavault4dbt | [Flow.BI: Generating the Raw Data Vault Using AI and dbt](https://www.scalefree.com/blog/modeling/flow-bi-generating-the-raw-data-vault-using-ai-and-dbt/) | Explains the logical-to-physical automation chain and connector, and the addition of business logic in the Business Vault. Pair it with the [FCT access page](https://www.scalefree.com/consulting/turbovault/flowbi-connector/) for onboarding. |
| TurboVault | [Speed Up Your Data Vault 2.0 Implementation with TurboVault4dbt](https://www.scalefree.com/blog/tools/speed-up-your-data-vault-2-0-implementation-with-turbovault4dbt/) | Introduces metadata-driven dbt model generation. Use it to understand the generation stage before the review phase. |
| datavault4dbt overview | [Kick-Start Your Data Vault 2.0 Implementation with datavault4dbt](https://www.scalefree.com/blog/tools/kick-start-your-data-vault-2-0-implementation-with-datavault4dbt/) | Introduces loading templates and the package's role within dbt. Useful background before the hands-on training. |
| datavault4dbt staging | [Exploring datavault4dbt — Vol. 1: The Staging Layer](https://www.scalefree.com/blog/tools/exploring-datavault4dbt-a-practical-series-on-the-dbt-package-for-data-vault-2-0-vol-1-the-staging-layer/) | Covers staging configuration, hashing, derived columns, and prejoins. Apply these concepts when connecting the Fivetran landing datasets to generated transformations. |
| datavault4dbt Raw Vault | [Exploring datavault4dbt — Vol. 2: Standard Entities in the Raw Vault](https://www.scalefree.com/blog/datenwerkzeuge/exploring-datavault4dbt-a-practical-series-on-the-dbt-package-for-data-vault-2-0-vol-2-standard-entities-in-the-raw-vault/) | Walks through hubs, links, and satellites. Use it to interpret the models produced by TurboVault and their macro parameters. |
| Business Vault extensions | [Designing the Business Vault: Key Strategies for Effective Data Organization](https://www.scalefree.com/blog/data-vault/designing-the-business-vault-key-strategies-for-effective-data-organization/) | Explains reusable business logic and additional entities such as computed satellites, links, PITs, and bridges. Relevant to user-defined organization extensions after Raw Vault generation. |
| dbt delivery and testing | [CI/CD: Practical Insights into Automating Data Vault 2.0 with dbt](https://www.scalefree.com/blog/data-vault/ci-cd-practical-insights-into-automating-data-vault-2-0-with-dbt/) | Uses datavault4dbt and GitHub Actions to illustrate testing and delivery automation. Adapt execution and runner placement to the organization's cloud boundary. |

Examples in older articles may use earlier package versions, metadata layouts, or specific cloud databases. Use the pinned tool versions and current documentation for implementation details. For ingestion and target-platform configuration, use the primary documentation already linked in the platform and ingestion guidance in this document alongside these architectural resources. Browse the [Scalefree blog](https://www.scalefree.com/blog/) for further articles.


## Flow.BI implementation resources

Use the [Flow.BI blog](https://flow.bi/blog/) for ongoing product architecture and implementation material. Relevant starting points:

| Resource | Why it matters to this blueprint |
| --- | --- |
| [How Flow.BI Protects Sensitive Enterprise Data](https://flow.bi/blog/how-flow-bi-protects-sensitive-enterprise-data/) | Explains required data profiling, the local Docker image, storage access, and the local/backend processing boundary. |
| [Seeing Every Step: Data Lineage Inside Flow.BI](https://flow.bi/blog/seeing-every-step-data-lineage-inside-flow-bi/) | Describes source-to-model traceability and graph views. Use this model lineage alongside Fivetran load evidence and dbt execution lineage. |
| [Turning Salesforce and Pardot Tables Into a Semantic Model](https://flow.bi/blog/turning-salesforce-and-pardot-tables-into-a-semantic-model/) | Illustrates concept recognition and declared versus inferred relationships using CRM data. Use it as background on model generation; organization-specific additions in this blueprint are implemented through Business Vault entities. |
| [Generative AI for Data Vault](https://flow.bi/ai-driven-business/) | Explains the progression from data profiling to a logical Data Vault model and downstream physical-model automation. |
| [Flow.BI Media Library](https://flow.bi/media/) | Includes local-processing, bring-your-own-bucket, modeling, and dbt integration sessions for team onboarding. |


## Questions about biotechnology and clinical research analytics on Snowflake

### How should Snowflake preserve biotechnology and clinical research history?

Separate source landing, dbt transformations and reporting workloads. For study, protocol version, and site, preserve source keys and effective/load times before building protocol/visit mappings, specimen lineage, analysis-population membership, and frozen-data snapshot manifests. Test historical corrections under concurrent SQL demand and attribute virtual-warehouse usage to the accepted product.

### What should the biotechnology and clinical research Snowflake pilot prove?

Use the worked example and difficult cases to validate **Connect study versions, participant visits, specimens, assays, and analysis snapshots while preserving blinding and protocol meaning**. Retain source-to-output reconciliation, duplicate and late-record results, access-denial evidence, restore behavior and the measured cost per accepted product. Confirm that regeneration preserves user-authored Business Vault rules and that DataHub lineage covers the actual route.

## Related blueprints

- [Sovereign biotechnology and clinical research data platform](../../sovereign/sovereign-biotechnology-and-clinical-research-data-platform-blueprint.md)
- [Biotechnology and Clinical Research cloud platform selection](../cloud-biotechnology-and-clinical-research-platform-selection-guide.md)
- [Biotechnology and Clinical Research on Databricks](../databricks/cloud-biotechnology-and-clinical-research-databricks-data-platform-blueprint.md)
- [Biotechnology and Clinical Research on Microsoft Fabric](../microsoft-fabric/cloud-biotechnology-and-clinical-research-microsoft-fabric-data-platform-blueprint.md)
- [Biotechnology and Clinical Research on Google BigQuery](../google-bigquery/cloud-biotechnology-and-clinical-research-google-bigquery-data-platform-blueprint.md)
- [Snowflake technology architecture](../../../../cloud/snowflake/snowflake-data-platform-blueprint.md)
- [All industry and technology blueprints](../../../../README.md)

## Next steps

Bring the biotechnology and clinical research worked example, source inventory, Snowflake deployment assumptions and measured cost targets to the first implementation session. Request a pilot covering ingestion, model generation, the review after TurboVault, dbt execution, DataHub lineage and one user-authored Business Vault extension.

Include DataHub metadata discovery, glossary ownership, lineage coverage, and catalog operating cost in the pilot scope.


Select the pilot described in this blueprint, name its business and technical owners, and bring representative source data, reporting definitions, workload volumes, and operating constraints to an architecture discussion.

| Step | Where to go | What to request or prepare |
| --- | --- | --- |
| Discuss the implementation | [Scalefree contact form](https://www.scalefree.com/about-scalefree/contact/) | Request a platform assessment, pilot workshop, implementation support, or tailored training. Include the blueprint title and the first data product. |
| Try automated modeling | [Flow.BI trial registration](https://flow.bi/sign-up-for-trial/) | Request a trial and local-processing Docker deployment instructions. Prepare authorized source data; available metadata improves the result. |
| Obtain the connector | [FCT access and download request](https://www.scalefree.com/consulting/turbovault/flowbi-connector/) | Request Flow.BI Connector for TurboVault4dbt access and verify the intended generator version. |
| Install the macro package | [datavault4dbt repository and releases](https://github.com/ScalefreeCOM/datavault4dbt) | Obtain the package, choose a supported target adapter, and pin a tested version. |
| Access the online generator | [Request TurboVault Studio signup through Scalefree](https://www.scalefree.com/about-scalefree/contact/) | Ask specifically for the new online TurboVault Studio and its Flow.BI/FCT integration route. |
| Obtain a downloadable generator | [TurboVault4dbt](https://github.com/ScalefreeCOM/turbovault4dbt) and [TurboVault Engine](https://github.com/ScalefreeCOM/turbovault-engine) | Select the edition that fits the integration and retain its version and configuration. |
| Receive implementation updates | [Scalefree newsletter registration](https://www.scalefree.com/) | Use the “Data Vault 2.GO / Build Better Data Platforms” newsletter form on the homepage. |

Complete the pilot's reconciliation, access, recovery, and cost checks before extending the source scope. Record the results and the decision to proceed in the project repository.


## License

Copyright © 2026 Scalefree International GmbH. The original text, tables, and diagrams in this blueprint are licensed under [CC BY-SA 4.0](https://creativecommons.org/licenses/by-sa/4.0/). Credit Scalefree, identify changes, and retain the applicable ShareAlike terms when distributing adaptations. See [LICENSE.md](../../../../LICENSE.md) for scope, attribution, and the governing legal code. Referenced software and third-party material retain their own licenses.
